Opendata, web and dolomites

GUTPEPTIDES SIGNED

Novel therapeutic approaches to improve gastrointestinal wound healing

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GUTPEPTIDES project word cloud

Explore the words cloud of the GUTPEPTIDES project. It provides you a very rough idea of what is the project "GUTPEPTIDES" about.

bowel    action    nervous    receptor    protection    assays    mechanisms    pain    regulate    accessible    restores    pave    oxytocin    elucidate    tackle    diverse    stability    modulating    tools    significantly    diseases    gastrointestinal    intriguing    leads    longer    strategy    molecular    mechanism    physical    diversity    protects    repair    wound    suitable    inflammation    healing    immune    biological    explore    peptides    potentially    probes    discover    brain    mouse    receptors    explores    compromised    irritable    synthesis    therapeutic    trefoil    grafting    source    drug    disorders    pharmacology    treating    treatment    prevention    models    reveal    characterise    controls    venoms    ligands    scaffold    innovative    therapeutics    multidisciplinary    epithelial    treat    gut    complementary    epithelium    content    inflammatory    axis    syndrome    barrier    central    disease    immunogenic    permeability    symptoms    toxic    employ    peptide    once    think   

Project "GUTPEPTIDES" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAT WIEN 

Organization address
address: UNIVERSITATSRING 1
city: WIEN
postcode: 1010
website: www.univie.ac.at

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 1˙487˙396 €
 EC max contribution 1˙487˙396 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-STG
 Funding Scheme ERC-STG
 Starting year 2017
 Duration (year-month-day) from 2017-09-01   to  2022-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAT WIEN AT (WIEN) coordinator 1˙487˙396.00

Map

 Project objective

The gastrointestinal epithelium is a major physical barrier that protects us from diverse and potentially immunogenic or toxic content. A compromised epithelium results in increased permeability to such content, thus leading to inflammation, immune response, pain, and diseases, such as irritable bowel syndrome and inflammatory bowel disease. A therapeutic strategy that controls inflammation and restores the barrier represents an innovative approach for the prevention and treatment of such diseases. This proposal focuses on how gut peptides regulate epithelial protection and repair, and explores novel therapeutic opportunities by targeting gut receptors that become accessible once the epithelium is compromised. We propose to tackle the overall aim of improving gastrointestinal wound healing via three complementary objectives: (I) to investigate the therapeutic potential of the oxytocin receptor during gastrointestinal inflammation, (II) to elucidate the mechanism of trefoil factor peptide-induced gastrointestinal wound healing, and (III) to discover and characterise novel ligands suitable for epithelial repair. To achieve these objectives, we employ a multidisciplinary approach that includes state-of-the-art peptide synthesis, scaffold grafting, pharmacology, gut stability and wound healing assays, and inflammatory mouse models. We will develop probes to study the mechanisms of action at a molecular level that is not possible with current tools, and explore the biological diversity of venoms for novel therapeutic leads. This project will significantly advance our understanding of epithelial protection/repair and reveal drug targets that treat the source of the problems rather than the symptoms. This project has the potential to change the way we think about treating gut disorders and how to develop peptide therapeutics, and it will pave the way towards the intriguing and longer-term goal of modulating the central nervous system via the gut-brain axis.

 Publications

year authors and title journal last update
List of publications.
2018 Zita Liutkevičiūtė, Esther Gil-Mansilla, Thomas Eder, Barbara Casillas-Pérez, Maria Giulia Di Giglio, Edin Muratspahić, Florian Grebien, Thomas Rattei, Markus Muttenthaler, Sylvia Cremer, Christian W. Gruber
Oxytocin-like signaling in ants influences metabolic gene expression and locomotor activity
published pages: 6808-6821, ISSN: 0892-6638, DOI: 10.1096/fj.201800443
The FASEB Journal 32/12 2019-05-23
2018 Anne C. Conibear, Markus Muttenthaler
Advancing the Frontiers of Chemical Protein Synthesis—The 7th CPS Meeting, Haifa, Israel
published pages: 247-254, ISSN: 2451-9456, DOI: 10.1016/j.chembiol.2018.03.001
Cell Chemical Biology 25/3 2019-05-23
2019 Nayara Braga Emidio, Werner Hoffmann, Stuart M. Brierley, Markus Muttenthaler
Trefoil Factor Family: Unresolved Questions and Clinical Perspectives
published pages: 387-390, ISSN: 0968-0004, DOI: 10.1016/j.tibs.2019.01.004
Trends in Biochemical Sciences 44/5 2019-05-23
2018 Volker Herzig, Aline de Araujo, Kathryn Greenwood, Yanni Chin, Monique Windley, Youmie Chong, Markus Muttenthaler, Mehdi Mobli, Neil Audsley, Graham Nicholson, Paul Alewood, Glenn King
Evaluation of Chemical Strategies for Improving the Stability and Oral Toxicity of Insecticidal Peptides
published pages: 90, ISSN: 2227-9059, DOI: 10.3390/biomedicines6030090
Biomedicines 6/3 2019-05-23
2018 Sarah Arrowsmith, Peter Keov, Markus Muttenthaler, Christian W. Gruber
Contractility Measurements of Human Uterine Smooth Muscle to Aid Drug Development
published pages: , ISSN: 1940-087X, DOI: 10.3791/56639
Journal of Visualized Experiments 131 2019-05-23
2017 Markus Muttenthaler, Åsa Andersson, Irina Vetter, Rohit Menon, Marta Busnelli, Lotten Ragnarsson, Christian Bergmayr, Sarah Arrowsmith, Jennifer R. Deuis, Han Sheng Chiu, Nathan J. Palpant, Margaret O’Brien, Terry J. Smith, Susan Wray, Inga D. Neumann, Christian W. Gruber, Richard J. Lewis, Paul F. Alewood
Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species
published pages: eaan3398, ISSN: 1937-9145, DOI: 10.1126/scisignal.aan3398
Science Signaling 10/508 2019-05-23

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GUTPEPTIDES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GUTPEPTIDES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

Resonances (2019)

Resonances and Zeta Functions in Smooth Ergodic Theory and Geometry

Read More  

LO-KMOF (2019)

Vapour-deposited metal-organic frameworks as high-performance gap-filling dielectrics for nanoelectronics

Read More  

HydroLieve (2018)

A long-lasting non-migrating hydrogel for relieving chronic pain

Read More